請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76677
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳益群(Yi-Chun Wu) | |
dc.contributor.author | Yi-Pei Chen | en |
dc.contributor.author | 陳宜佩 | zh_TW |
dc.date.accessioned | 2021-07-10T21:34:54Z | - |
dc.date.available | 2021-07-10T21:34:54Z | - |
dc.date.copyright | 2016-11-02 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-17 | |
dc.identifier.citation | Adams, J. M., & Cory, S. (2001). Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci, 26(1), 61-66.
Ashkenazi, A., & Dixit, V. M. (1998). Death receptors: signaling and modulation. Science, 281(5381), 1305-1308. Cai, J., Yang, J., & Jones, D. P. (1998). Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta, 1366(1-2), 139-149. Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y. M., Scott, H., Hession, C., . . . Browning, J. L. (1997). TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem, 272(51), 32401-32410. Chien, S. C., Brinkmann, E. M., Teuliere, J., & Garriga, G. (2013). Caenorhabditis elegans PIG-1/MELK acts in a conserved PAR-4/LKB1 polarity pathway to promote asymmetric neuroblast divisions. Genetics, 193(3), 897-909. doi:10.1534/genetics.112.148106 Chinnaiyan, A. M. (1999). The apoptosome: heart and soul of the cell death machine. Neoplasia, 1(1), 5-15. Chinnaiyan, A. M., Chaudhary, D., O'Rourke, K., Koonin, E. V., & Dixit, V. M. (1997). Role of CED-4 in the activation of CED-3. Nature, 388(6644), 728-729. doi:10.1038/41913 Chung, S., Gumienny, T. L., Hengartner, M. O., & Driscoll, M. (2000). A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat Cell Biol, 2(12), 931-937. doi:10.1038/35046585 Conradt, B., & Horvitz, H. R. (1998). The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell, 93(4), 519-529. Cordes, S., Frank, C. A., & Garriga, G. (2006). The C. elegans MELK ortholog PIG-1 regulates cell size asymmetry and daughter cell fate in asymmetric neuroblast divisions. Development, 133(14), 2747-2756. doi:10.1242/dev.02447 Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102(1), 33-42. Earnshaw, W. C. (1999). Apoptosis. A cellular poison cupboard. Nature, 397(6718), 387, 389. doi:10.1038/17015 Ekshyyan, O., & Aw, T. Y. (2004). Apoptosis: a key in neurodegenerative disorders. Curr Neurovasc Res, 1(4), 355-371. Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35(4), 495-516. doi:10.1080/01926230701320337 Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., . . . Takahashi, M. (2005). Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell, 9(3), 389-402. doi:10.1016/j.devcel.2005.08.001 Fadeel, B., Gleiss, B., Hogstrand, K., Chandra, J., Wiedmer, T., Sims, P. J., . . . Samali, A. (1999). Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun, 266(2), 504-511. doi:10.1006/bbrc.1999.1820 Fadok, V. A., & Chimini, G. (2001). The phagocytosis of apoptotic cells. Semin Immunol, 13(6), 365-372. doi:10.1006/smim.2001.0333 Fares, M., Abou-Seri, S. M., Abdel-Aziz, H. A., Abbas, S. E., Youssef, M. M., & Eladwy, R. A. (2014). Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. Eur J Med Chem, 83, 155-166. doi:10.1016/j.ejmech.2014.06.027 Frank, C. A., Hawkins, N. C., Guenther, C., Horvitz, H. R., & Garriga, G. (2005). C. elegans HAM-1 positions the cleavage plane and regulates apoptosis in asymmetric neuroblast divisions. Dev Biol, 284(2), 301-310. doi:10.1016/j.ydbio.2005.05.026 Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A., & Sabatini, D. M. (2006). mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol, 16(18), 1865-1870. doi:10.1016/j.cub.2006.08.001 Glucksmann, A. (1951). Cell deaths in normal vertebrate ontogeny. Biol Rev Camb Philos Soc, 26(1), 59-86. Grimm, S., Stanger, B. Z., & Leder, P. (1996). RIP and FADD: two 'death domain'-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci U S A, 93(20), 10923-10927. Gumienny, T. L., Brugnera, E., Tosello-Trampont, A. C., Kinchen, J. M., Haney, L. B., Nishiwaki, K., . . . Ravichandran, K. S. (2001). CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell, 107(1), 27-41. Hamilton, D. L., Philp, A., MacKenzie, M. G., Patton, A., Towler, M. C., Gallagher, I. J., . . . Baar, K. (2014). Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation. Am J Physiol Endocrinol Metab, 307(4), E365-373. doi:10.1152/ajpendo.00674.2013 Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., . . . Yonezawa, K. (2002). Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell, 110(2), 177-189. Hengartner, M. O. (1999). Programmed cell death in the nematode C. elegans. Recent Prog Horm Res, 54, 213-222; discussion 222-214. Hengartner, M. O., Ellis, R. E., & Horvitz, H. R. (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature, 356(6369), 494-499. doi:10.1038/356494a0 Hill, M. M., Adrain, C., Duriez, P. J., Creagh, E. M., & Martin, S. J. (2004). Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. Embo j, 23(10), 2134-2145. doi:10.1038/sj.emboj.7600210 Horvitz, H. R. (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res, 59(7 Suppl), 1701s-1706s. Hsu, H., Xiong, J., & Goeddel, D. V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell, 81(4), 495-504. Hung, C. M., Garcia-Haro, L., Sparks, C. A., & Guertin, D. A. (2012). mTOR-dependent cell survival mechanisms. Cold Spring Harb Perspect Biol, 4(12). doi:10.1101/cshperspect.a008771 Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K. L. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol, 4(9), 648-657. doi:10.1038/ncb839 Iwahana, H., Fujimura, M., Ii, S., Kondo, M., Moritani, M., Takahashi, Y., . . . Itakura, M. (1996). Molecular cloning of a human cDNA encoding a trifunctional enzyme of carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase in de Novo pyrimidine synthesis. Biochem Biophys Res Commun, 219(1), 249-255. doi:10.1006/bbrc.1996.0213 Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A., & Hall, M. N. (2004). Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol, 6(11), 1122-1128. doi:10.1038/ncb1183 Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K., . . . Mizushima, N. (2010). Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J Biol Chem, 285(26), 20109-20116. doi:10.1074/jbc.M110.121699 Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G., & Ahringer, J. (2001). Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol, 2(1), Research0002. doi:10.1186/gb-2000-2-1-research0002 Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo j, 14(22), 5579-5588. Laplante, M., & Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell, 149(2), 274-293. doi:10.1016/j.cell.2012.03.017 Lettre, G., & Hengartner, M. O. (2006). Developmental apoptosis in C. elegans: a complex CEDnario. Nat Rev Mol Cell Biol, 7(2), 97-108. doi:10.1038/nrm1836 Lockshin, R. A., & Zakeri, Z. (2001). Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol, 2(7), 545-550. doi:10.1038/35080097 Lopez-Saez, J. F., de la Torre, C., Pincheira, J., & Gimenez-Martin, G. (1998). Cell proliferation and cancer. Histol Histopathol, 13(4), 1197-1214. Matsura, T., Serinkan, B. F., Jiang, J., & Kagan, V. E. (2002). Phosphatidylserine peroxidation/externalization during staurosporine-induced apoptosis in HL-60 cells. FEBS Lett, 524(1-3), 25-30. Nakashima, A., Kawanishi, I., Eguchi, S., Yu, E. H., Eguchi, S., Oshiro, N., . . . Yonezawa, K. (2013). Association of CAD, a multifunctional protein involved in pyrimidine synthesis, with mLST8, a component of the mTOR complexes. J Biomed Sci, 20, 24. doi:10.1186/1423-0127-20-24 Nellist, M., Burgers, P. C., van den Ouweland, A. M., Halley, D. J., & Luider, T. M. (2005). Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. Biochem Biophys Res Commun, 333(3), 818-826. doi:10.1016/j.bbrc.2005.05.175 Norbury, C. J., & Hickson, I. D. (2001). Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol, 41, 367-401. doi:10.1146/annurev.pharmtox.41.1.367 Parrish, A. B., Freel, C. D., & Kornbluth, S. (2013). Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol, 5(6). doi:10.1101/cshperspect.a008672 Pearce, L. R., Huang, X., Boudeau, J., Pawlowski, R., Wullschleger, S., Deak, M., . . . Alessi, D. R. (2007). Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem J, 405(3), 513-522. doi:10.1042/bj20070540 Reardon, M. A., & Weber, G. (1985). Increased carbamoyl-phosphate synthetase II concentration in rat hepatomas: immunological evidence. Cancer Res, 45(9), 4412-4415. Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., . . . Hall, M. N. (2013). Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science, 339(6125), 1320-1323. doi:10.1126/science.1228771 Saelens, X., Festjens, N., Vande Walle, L., van Gurp, M., van Loo, G., & Vandenabeele, P. (2004). Toxic proteins released from mitochondria in cell death. Oncogene, 23(16), 2861-2874. doi:10.1038/sj.onc.1207523 Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., . . . Sabatini, D. M. (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell, 25(6), 903-915. doi:10.1016/j.molcel.2007.03.003 Saraste, A., & Pulkki, K. (2000). Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res, 45(3), 528-537. Sato, T., Akasu, H., Shimono, W., Matsu, C., Fujiwara, Y., Shibagaki, Y., . . . Hattori, S. (2015). Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity. J Biol Chem, 290(2), 1096-1105. doi:10.1074/jbc.M114.592402 Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002). A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol, 2(12), 965-975. doi:10.1038/nri957 Shaham, S., & Horvitz, H. R. (1996). Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev, 10(5), 578-591. Sigoillot, F. D., Kotsis, D. H., Serre, V., Sigoillot, S. M., Evans, D. R., & Guy, H. I. (2005). Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD. J Biol Chem, 280(27), 25611-25620. doi:10.1074/jbc.M504581200 Smith, K. A., Agarwal, M. L., Chernov, M. V., Chernova, O. B., Deguchi, Y., Ishizaka, Y., . . . Stark, G. R. (1995). Regulation and mechanisms of gene amplification. Philos Trans R Soc Lond B Biol Sci, 347(1319), 49-56. doi:10.1098/rstb.1995.0008 Soliman, G. A. (2013). The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses. Nutrients, 5(6), 2231-2257. doi:10.3390/nu5062231 Sulston, J. E. (1983). Neuronal cell lineages in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol, 48 Pt 2, 443-452. Teuliere, J., Cordes, S., Singhvi, A., Talavera, K., & Garriga, G. (2014). Asymmetric neuroblast divisions producing apoptotic cells require the cytohesin GRP-1 in Caenorhabditis elegans. Genetics, 198(1), 229-247. doi:10.1534/genetics.114.167189 van Loo, G., van Gurp, M., Depuydt, B., Srinivasula, S. M., Rodriguez, I., Alnemri, E. S., . . . Vandenabeele, P. (2002). The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ, 9(1), 20-26. doi:10.1038/sj.cdd.4400970 Wajant, H. (2002). The Fas signaling pathway: more than a paradigm. Science, 296(5573), 1635-1636. doi:10.1126/science.1071553 Wang, X., Wu, Y. C., Fadok, V. A., Lee, M. C., Gengyo-Ando, K., Cheng, L. C., . . . Xue, D. (2003). Cell corpse engulfment mediated by C. elegans phosphatidylserine receptor through CED-5 and CED-12. Science, 302(5650), 1563-1566. doi:10.1126/science.1087641 Wu, Y. C., Tsai, M. C., Cheng, L. C., Chou, C. J., & Weng, N. Y. (2001). C. elegans CED-12 acts in the conserved crkII/DOCK180/Rac pathway to control cell migration and cell corpse engulfment. Dev Cell, 1(4), 491-502. Zuzarte-Luis, V., & Hurle, J. M. (2002). Programmed cell death in the developing limb. Int J Dev Biol, 46(7), 871-876. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76677 | - |
dc.description.abstract | 細胞凋亡(Apoptosis)是一種計畫性細胞死亡(Programmed cell death, PCD)的形式,這項過程在生物體發育過程中是非常重要的,此過程受到了很多基因嚴格的調控。我們實驗室之前係用線蟲這個模式生物做了基因篩選實驗,同時將調控計畫性細胞死亡的基因與調控細胞不對稱分裂(Asymmetric cell division)的基因突變掉,使線蟲在尾部產生額外存活的hyp8/9細胞,形成了「tail defect」的表現型。利用這種在調控細胞不對稱分裂的基因突變背景下,找出了183可能調控計畫性細胞死亡的突變,tp12是其中一個突變,tp12是在pyr-1基因上的突變,其在哺乳動物中的同源基因為cad,是合成嘧啶(pyrimidine)的重要基因。我們發現在pyr-1的突變在grp-1突變的情況下造成了額外的hyp8/9細胞與分泌細胞的存活,並且其單獨的突變造成了死細胞(cell corpse)數目下降了。此外在pyr-1; grp-1的線蟲中額外補充尿嘧啶也無法使tail defect恢復成野生型的樣子,這訴說著pyr-1的突變所造成額外細胞存活的情形與其調控嘧啶合成的功能無關。在我的研究結果中發現當pyr-1與另一個調控細胞不對稱分裂的基因pig-1同時突變時也會產生tail defect的表現型,這更證明了pyr-1是一個調控細胞凋亡的基因。此外,雖然有文獻指出哺乳動物中mTOR會調控CAD的活性,但是我的研究中在pyr-1(tp12)的線蟲中使mTOR表現量減少並不會影響死細胞的數量也不會影響tail defect,表示pyr-1調控細胞凋亡不需要透過mTOR路徑。更重要的是在staurosporine處理以及用紫外光照射誘導細胞凋亡的形況下使人類子宮頸癌細胞(HeLa)中CAD的表現量下降細胞的死亡率會下降。此外我們利用細胞螢光染色的方式觀察到全長的CAD均勻散佈在細胞質中,截切之後的CAD雖然也是表現在細胞質,但其呈現的是點狀的分布型態,且這樣的分布形式在線蟲中也同樣存在。透過上述的研究結果我們發現PYR-1/CAD除了具有能夠調控嘧啶合成過程的功能外還同時具有能夠促進細胞凋亡的功能,且這項功能在線蟲與人類細胞株間高度保留。 | zh_TW |
dc.description.abstract | Apoptosis, a form of programmed cell death (PCD), is a fundamental process during development and is tightly regulated by numerous genes. Previously, based on the observation that blockage of both PCD and asymmetric cell division (ACD) caused extra hyp8/9 hypodermal cell(s) and resulted in a tail defect phenotype, an enhancer genetic screen was conducted in a ACD-defective (grp-1 mutant) background to identify new PCD genes. 183 mutants were isolated from this screen and one was PYR-1, the C. elegans homolog of mammalian CAD which is essential for pyrimidine synthesis. Mutations in pyr-1 caused extra hyp8/9 and excretory cell(s) in the grp-1 mutant background and also caused a reduced number of cell corpses alone. Besides the tail defect in pyr-1; grp-1 could not be rescued by uracil supplement, indicating that pyr-1 regulated the survival of hyp8/9 cell in addition to its enzymatic activity of pyrimidine synthesis. In this thesis, we find that the pyr-1(tp12) mutant, like other PCD-defective mutants, also causes tail defects in the pig-1 mutant background, further supporting that pyr-1 is a ced (cell death abnormal) gene. Furthermore, although CAD interacts with mTOR in mammalian cell lines, knockdown of the mTOR pathway has no effect on PCD-defective phenotypes in the pyr-1 mutant, indicating that pyr-1 does not act through the mTOR pathway to elicit its cell death-promoting activity. Most importantly, knockdown of CAD attenuates apoptosis induced by staurosporine or UV irradiation in HeLa cells. Interestingly, full-length CAD is detected in cytoplasm diffusely, whereas truncated CAD shows cytoplasmic puncta. These observations are consistent with the expression of PYR-1 and truncated PYR-1 in C. elegans. Our findings indicate a conserved pro-apoptotic role and mechanism of PYR-1/CAD in C. elegans and humans; through investigating the pro-apoptotic genes may help to understand the potential reason which caused the diseases raised from dysregulation of apoptosis and may provide a therapeutic strategy for these diseases. | en |
dc.description.provenance | Made available in DSpace on 2021-07-10T21:34:54Z (GMT). No. of bitstreams: 1 ntu-105-R03b43010-1.pdf: 1009964 bytes, checksum: 82d1dd86a8684a02990db1ef98fc1e9a (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 致謝................................................................................................................................. I
中文摘要....................................................................................................................... II Abstract ....................................................................................................................... IV Table of Contents ......................................................................................................... 1 Introduction .................................................................................................................. 3 Methods ....................................................................................................................... 15 C. elegans Strains......................................................................................................... 15 RNA interference ......................................................................................................... 15 Cell death assays .......................................................................................................... 16 Cell Culture and In Vitro Assays ................................................................................. 16 shRNA Lentivirus Knockdown Assay ......................................................................... 17 Immunofluorescence .................................................................................................... 18 UV Irradiation Assay ................................................................................................... 18 Flow Cytometric Measurement of Annexin-V/ Propidium Iodide Staining ................ 18 Non-Radioactive Cell Proliferation Assay (MTS) ....................................................... 19 Results ......................................................................................................................... 20 The pyr-1(tp12) mutation enhanced the tail defect of the pig-1(gm344) mutant, but caused no extra excretory cells in the pig-1(gm344) background. .............................. 20 The pyr-1(tp12) mutation caused a decreased number of cell corpses in C. elegans embryos ........................................................................................................................ 21 pyr-1 does not act through the mTOR pathway to promote PCD................................ 22 Several cancer samples and cancer cell lines possess mutation(s) on the CAD loci ... 23 Overexpression of CAD did not promote cell death in DLD-1 and HUTU-80 ........... 24 Knockdown of CAD reduced apoptosis in HeLa cells ................................................ 25 The localization of CAD may change after cleavage by caspase-3 ............................. 28 Discussion.................................................................................................................... 29 CAD unexpectedly has a pro-apoptotic function ......................................................... 29 CAD likely translocalizes to organelles after cleaved by caspase-3 ............................ 31 PYR-1 does not promote PCD through the mTOR pathway ....................................... 32 GRP-1 and PIG-1 may have different functions in either different cellular processes or different cells ............................................................................................................. 32 PCD is affected by different diets in pyr-1(tp12) mutant background ........................ 34 Figure .......................................................................................................................... 36 Figure 1. The pry-1(tp12) mutation enhanced the tail defect but caused no extra excretory cell in the pig-1(gm344) background. .......................................................... 36 Figure 2. The pyr-1(tp12) mutation caused a decreased number of cell corpses in C. elegans embryos........................................................................................................... 37 Figure 3. PYR-1 promotes PCD through mTOR-independent pathway. .................... 38 Figure 4. Overexpression of CAD fails to promote apoptosis in Hutu-80 and DLD-1. ...................................................................................................................................... 39 Figure 5. Knockdown of CAD reduced apoptosis in HeLa cells. ................................ 42 Figure 6. Loss of CAD caused a higher mitochondrial activity after STS treatment in HeLa cells. ................................................................................................................... 44 Figure 7. Loss of CAD resulted in reduced apoptosis after UV irradiation in HeLa cells. ............................................................................................................................. 45 Figure 8. The expression pattern of tCAD is different from that of full-length in HeLa cells.. ............................................................................................................................ 46 Table ............................................................................................................................ 47 Table 1. Several cancer cell lines possess mutation(s) on the CAD loci. .................... 47 Supplementary Figure ............................................................................................... 48 Figure S1. PCD is affected by different diets in pyr-1(tp12) mutant background.. ..... 48 Reference .................................................................................................................... 49 | |
dc.language.iso | en | |
dc.title | 探討CAD在線蟲與人類癌症細胞中促進細胞凋亡的功能 | zh_TW |
dc.title | Investigating the Pro-apoptotic Function of CAD in C. elegans and Human Cancer Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 江皓森(Hao-Sen Chiang),吳瑞菁(Jui-Ching Wu) | |
dc.subject.keyword | 線蟲,癌症,細胞凋亡, | zh_TW |
dc.subject.keyword | C. elegans,cancer,cell apoptosis, | en |
dc.relation.page | 62 | |
dc.identifier.doi | 10.6342/NTU201602776 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2016-08-18 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 分子與細胞生物學研究所 | zh_TW |
顯示於系所單位: | 分子與細胞生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-R03b43010-1.pdf 目前未授權公開取用 | 986.29 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。